Yes Bee:
"Twelve companies making twelve things they have never made before ..." and enough of the twelve made sufficient mess of the trial that they managed to turn the Australian results upside down, rather than just producing burnt porridge.
... and it all happened by accident.
- Forums
- ASX - By Stock
- BOT
- Antimicrobial platform - BTX 1801 Phase 2a clinical study
Antimicrobial platform - BTX 1801 Phase 2a clinical study, page-8
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 470483 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 33000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 467608 | 0.315 |
27 | 806928 | 0.310 |
11 | 241226 | 0.305 |
31 | 495096 | 0.300 |
6 | 120637 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 33000 | 1 |
0.325 | 176270 | 4 |
0.330 | 80538 | 3 |
0.335 | 285000 | 3 |
0.340 | 834146 | 6 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online